Professor Ryszard Jerzy Gryglewski: pioneer of pharmacology of vascular endothelium
Cardiovascular Research · 2023
DOI: 10.1093/cvr/cvad063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2023. Verfasst von Stefan Chlopicki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow 30-348, Poland. Hauptthemen laut MEDLINE: Endothelium, Vascular, Epoprostenol. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow 30-348, Poland.
- Department of Pharmacology, Jagiellonian University Medical College, Grzegorzecka 16, 31-531 Krakow, Poland.
- The William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
ORCID-Profile: Stefan Chlopicki
Zitieren
APA
Chlopicki, S., Olszanecki, R., & Flower, R. J. (2023). Professor Ryszard Jerzy Gryglewski: pioneer of pharmacology of vascular endothelium. Cardiovascular Research. https://doi.org/10.1093/cvr/cvad063
Vancouver
Chlopicki S, Olszanecki R, Flower RJ. Professor Ryszard Jerzy Gryglewski: pioneer of pharmacology of vascular endothelium. Cardiovascular Research. 2023. doi:10.1093/cvr/cvad063
BibTeX
@article{Chlopicki2023,
author = {Chlopicki, Stefan and Olszanecki, Rafal and Flower, Rod J},
title = {Professor Ryszard Jerzy Gryglewski: pioneer of pharmacology of vascular endothelium},
journal = {Cardiovascular Research},
year = {2023},
doi = {10.1093/cvr/cvad063}
}
EUVIMED